A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

ClinicalTrials.gov ID: NCT07483073

Public ClinicalTrials.gov record NCT07483073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization to a treatment group. The studies aim to evaluate the efficacy and safety of new treatments in adults with moderately to severely active ulcerative colitis or Crohn's disease and will last at least 62 weeks.

Study identification

NCT ID: NCT07483073
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 60 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 3, 2026
Primary completion: May 31, 2027
Completion: Feb 29, 2028
Last update posted: Aug 23, 2026

2026 – 2028

United States locations

U.S. sites: 14
U.S. states: 11
U.S. cities: 14

Facility	City	State	ZIP	Site status
Mayo Clinic in Arizona - Scottsdale	Scottsdale	Arizona	85259	Suspended
Biopharma Informatic, LLC	Los Angeles	California	90035	Recruiting
Om Research LLC	Oxnard	California	93030	Recruiting
South Denver Gastroenterology	Englewood	Colorado	80113	Recruiting
Gastro Health Research - Miami	Miami	Florida	33176	Recruiting
Ezy Medical Research	Miami Lakes	Florida	33015	Recruiting
Atlanta Gastroenterology Associates - Peachtree Dunwoody	Atlanta	Georgia	30342	Recruiting
Rush University Medical Center	Chicago	Illinois	60612	Not yet recruiting
Cotton O'Neil Digestive Health Center	Topeka	Kansas	66606	Recruiting
Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center	Wyoming	Michigan	49519	Recruiting
KAD Clinical Research	St Louis	Missouri	63123	Recruiting
Vector Clinical Trials	Las Vegas	Nevada	89128	Recruiting
One of a Kind Clinical Research Center - Kingwood	Kingwood	Texas	77339	Not yet recruiting
Southern Star Research Institute	San Antonio	Texas	78229	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07483073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 23, 2026 · Synced Sep 2, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07483073 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →